More Intellectual Property Articles

Healthcare | Life Sciences

Six Important Strategies To Reduce The Royalty Burden For A Pharmaceutical Product

A biotech or pharmaceutical company will often need to in-license certain inventions in order to develop and commercialize its products. The company will most likely be required to pay to its licensor a royalty based on sales of its products (licensed products) that exploit the licensed...

Read More

Intellectual Property

Former ITC Judge Brings Wealth Of Experience To Private Practice

Editor: Congratulations on joining Brinks Hofer Gilson & Lione (Brinks) in its U.S. International Trade Commission (ITC) practice. Please tell us about your background and experience. Charneski: Before joining Brinks, I was an ITC judge for four and a half years, though I often refer to...

Read More

Government Contracts

U.S. Supreme Court Upends Bayh-Dole - Federal Contractors And Grant Recipients Must Tie Up Employee Inventions Or Risk Losing Right To Retain Ownership Of Inventions Developed With Federal Funds

Pop Quiz: When The Government Pays For Know-How, Who Owns It?You're Wrong. It's Not The Government. A fundamental understanding shared by both new recipients of federal research and development funds and some of its most experienced grant recipients and contractors is that if the...

Read More